Dynavax Technologies Corporation

This study is testing a new vaccine designed to prevent pneumonic plague, a severe lung infection caused by bacteria. Researchers will give the vaccine to about 148 healthy adults aged 18-55 to see how well their immune systems respond and to check for side effects. The goal is t…

This study is testing a new investigational shingles vaccine called Z-1018. It will compare the safety and how well it triggers the immune system against the currently approved Shingrix vaccine. The trial will enroll about 764 healthy adults aged 50 and older to find the right do…